stimOS
OverviewSuggest Edit
stimOS is a company that develops a patented mimicking bone technology created to transform implant surfaces from an artificial barrier into a bone identical implant body interface. Its mimicking bone technology is a biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and fast healing process, enabling patients to get required possible recovery and achieve a pain-free life after surgery.
| Type | Private | |
| Founded | 2015 | |
| Website | smartimplants.net |
Recent NewsAll News
Latest Updates
| Employees (est.) (Jul 2021) | 4 | |
| Cybersecurity rating | A | More |
stimOS Financials and Metrics
Summary Metrics
Founding Date | 2015 |
stimOS total Funding | $839.5 k |
Time since last funding | a year ago |
stimOS investors | HTGF, MBG Baden Wuerttemberg, High-Tech Grunderfonds, WEFA Inotec, MBG, Dietmar Schaffarczyk |
stimOS Cybersecurity Score
stimOS Online and Social Media Presence
12 Twitter followers
stimOS has 12 Twitter Followers. The number of followers has decreased 2% quarter over quarter
stimOS's Trends
stimOS News and Updates
August 07, 2020
stimOS Raises Series A Funding Round
stimOS GmbH, a Constance, Germany-based medical technology company, raised a a Series A funding round of undisclosed amount. WEFA Inotec GmbH, a German market leader in extrusion tooling, precision technology and CVD coatings, participated in the round, along with HTGF, MBG and founding partner Diet…
stimOS Frequently Asked Questions
When was stimOS founded?
stimOS was founded in 2015.
How many employees does stimOS have?
stimOS has 4 employees.
Who are stimOS competitors?
Competitors of stimOS include Care & Planning for Hospitals, Keranova and SentreHEART.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies